Medical resource utilization of abiraterone acetate plus prednisone added to androgen deprivation therapy in metastatic castration-naive prostate cancer: Results from LATITUDE

Li, T; Franco-Villalobos, C; Proskorovsky, I; Sorensen, SV; Tran, N; Sulur, G; Chi, KN

Sorensen, SV (reprint author), Evidera, 7101 Wisconsin Ave,Suite 1400, Bethesda, MD 20814 USA.

CANCER, 2019; 125 (4): 626

Abstract

Background Abiraterone acetate plus prednisone (AA+P), when added to androgen deprivation therapy (ADT), demonstrated significant improvements in over......

Full Text Link